Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Valérie Proulx & Benoit Tousignant. (2021) Drugs of abuse and ocular effects. Clinical and Experimental Optometry 104:5, pages 567-578.
Read now
Read now
Joseph J. Palamar, Patricia Acosta, Fermín Fernández Calderón, Scott Sherman & Charles M. Cleland. (2017) Assessing self-reported use of new psychoactive substances: The impact of gate questions. The American Journal of Drug and Alcohol Abuse 43:5, pages 609-617.
Read now
Read now
Paul Gee, Leo J. Schep, Berit P. Jensen, Grant Moore & Stuart Barrington. (2016) Case series: toxicity from 25B-NBOMe – a cluster of N-bomb cases. Clinical Toxicology 54:2, pages 141-146.
Read now
Read now
Joseph J. Palamar, Mark K. Su & Robert S. Hoffman. (2016) Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011–2014. The American Journal of Drug and Alcohol Abuse 42:1, pages 39-47.
Read now
Read now
Sahaphume Srisuma, Alvin C. Bronstein & Christopher O. Hoyte. (2015) NBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System. Clinical Toxicology 53:7, pages 624-628.
Read now
Read now
David M. Wood, Roumen Sedefov, Andrew Cunningham & Paul I. Dargan. (2015) Prevalence of use and acute toxicity associated with the use of NBOMe drugs. Clinical Toxicology 53:2, pages 85-92.
Read now
Read now
Articles from other publishers (36)
Adam J. Potts, Simon H.L. Thomas & Simon L. Hill. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
279
300
.
Deborah Rudin, Matthias E. Liechti & Dino Luethi. (2021) Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Experimental Neurology 343, pages 113778.
Crossref
Crossref
Liana Fattore, Matteo Marti, Rafaela Mostallino & Maria Paola Castelli. (2020) Sex and Gender Differences in the Effects of Novel Psychoactive Substances. Brain Sciences 10:9, pages 606.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Jolanta B. Zawilska, Monika Kacela & Piotr Adamowicz. (2020) NBOMes–Highly Potent and Toxic Alternatives of LSD. Frontiers in Neuroscience 14.
Crossref
Crossref
Jee-Yeon Seo, Kwang-Hyun Hur, Yong-Hyun Ko, Kyungin Kim, Bo-Ram Lee, Young-Jung Kim, Seon-Kyung Kim, Seong-Eon Kim, Yong-Sup Lee, Hyoung-Chun Kim, Seok-Yong Lee & Choon-Gon Jang. (2019) A novel designer drug, 25N-NBOMe, exhibits abuse potential via the dopaminergic system in rodents. Brain Research Bulletin 152, pages 19-26.
Crossref
Crossref
Ana Maria dos Santos Moreira, Hanna Leijoto de Oliveira, João Francisco Allochio Filho, Diego Hernando Ângulo Florez, Marcela Matos Cordeiro Borges, Valdemar LacerdaJr.Jr., Wanderson Romão & Keyller Bastos Borges. (2019) NBOMe compounds: An overview about analytical methodologies aiming their determination in biological matrices. TrAC Trends in Analytical Chemistry 114, pages 260-277.
Crossref
Crossref
Seo Young Jeon, Young-Hoon Kim, Sung Jin Kim, Soo Kyung Suh & Hye Jin Cha. (2019) Abuse potential of 2-(4-iodo-2, 5-dimethoxyphenyl) N-(2-methoxybenzyl)ethanamine (25I NBOMe); in vivo and ex vivo approaches. Neurochemistry International 125, pages 74-81.
Crossref
Crossref
Peng Xu, Qiyang Qiu, Haijie Li, Sicheng Yan, Mengxiang Yang, C. Benjamin Naman, Youmei Wang, Wenhua Zhou, Haowei Shen & Wei Cui. (2019) 25C-NBOMe, a Novel Designer Psychedelic, Induces Neurotoxicity 50 Times More Potent Than Methamphetamine In Vitro. Neurotoxicity Research 35:4, pages 993-998.
Crossref
Crossref
Nino Cesar Marchi, Juliana Nichterwitz Scherer, Letícia Schwanck Fara, Lysa Remy, Rafaela Ornel, Monique Reis, Amanda Zamboni, Mariana Paim, Taís Regina Fiorentin, Carlos Alberto Yasin Wayhs, Lisia Von Diemen, Flavio Pechansky, Felix Henrique Paim Kessler & Renata Pereira Limberger. (2019) Clinical and Toxicological Profile of NBOMes: A Systematic Review. Psychosomatics 60:2, pages 129-138.
Crossref
Crossref
Joseph J. Palamar & Austin Le. (2019) Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005–2017. Human Psychopharmacology: Clinical and Experimental 34:2, pages e2690.
Crossref
Crossref
Amy J. Eshleman, Katherine M. Wolfrum, John F. Reed, Sunyoung O. Kim, Robert A. Johnson & Aaron Janowsky. (2018) Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT2A receptors. Biochemical Pharmacology 158, pages 27-34.
Crossref
Crossref
Glayton A. Souza, Dilton M. Pimentel, Amanda B. Lima, Tiago J. Guedes, Luciano C. Arantes, Anderson C. de Oliveira, Raquel M. F. Sousa, Rodrigo A. A. Muñoz & Wallans T. P. dos Santos. (2018) Electrochemical sensing of NBOMes and other new psychoactive substances in blotting paper by square-wave voltammetry on a boron-doped diamond electrode. Analytical Methods 10:20, pages 2411-2418.
Crossref
Crossref
Simon L. Hill & Paul I. Dargan. 2018. New Psychoactive Substances. New Psychoactive Substances
475
494
.
Xiongyu Wu, Caroline Eriksson, Ariane Wohlfarth, Jakob Wallgren, Robert Kronstrand, Martin Josefsson, Johan Dahlén & Peter Konradsson. (2017) Synthesis and identification of metabolite biomarkers of 25C-NBOMe and 25I-NBOMe. Tetrahedron 73:45, pages 6393-6400.
Crossref
Crossref
Keith-Dane H. Temporal, Karen S. Scott, Amanda L.A. Mohr & Barry K. Logan. (2017) Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine. Journal of Analytical Toxicology 41:7, pages 646-657.
Crossref
Crossref
Michael B. Gatch, Sean B. Dolan & Michael J. Forster. (2017) Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents. Behavioural Pharmacology 28:5, pages 375-385.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Ariane Wohlfarth, Markus Roman, Mikael Andersson, Fredrik C. Kugelberg, Xingxing Diao, Jeremy Carlier, Caroline Eriksson, Xiongyu Wu, Peter Konradsson, Martin Josefsson, Marilyn A. Huestis & Robert Kronstrand. (2017)
25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes,
in vivo
mouse and human urine with high-resolution mass spectrometry
. Drug Testing and Analysis 9:5, pages 680-698.
Crossref
Crossref
Line Marie Nielsen, Niels Bjerre Holm, Sebastian Leth-Petersen, Jesper Langgaard Kristensen, Lars Olsen & Kristian Linnet. (2017) Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH. Drug Testing and Analysis 9:5, pages 671-679.
Crossref
Crossref
Camille Richeval, Alexandra Boucher, Luc Humbert, Mélodie Phanithavong, Jean-François Wiart, Mustapha Moulsma, Antony Citterio-Quentin, Thierry Coulon, Romain Hernu, Thierry Vial, Delphine Allorge & Jean-Michel Gaulier. (2017) Retrospective identification of 25I-NBOMe metabolites in an intoxication case. Toxicologie Analytique et Clinique 29:1, pages 71-81.
Crossref
Crossref
Christine Murphy & George Sam Wang. 2017. Case Studies in Medical Toxicology. Case Studies in Medical Toxicology
79
88
.
Adam L. Halberstadt. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS)
283
311
.
Sabra Botch-Jones, Jamie Foss, David Barajas, Frank Kero, Craig Young & Jason Weisenseel. (2016) The detection of NBOMe designer drugs on blotter paper by high resolution time-of-flight mass spectrometry (TOFMS) with and without chromatography. Forensic Science International 267, pages 89-95.
Crossref
Crossref
John J. Kristofic, Jeffrey D. Chmiel, George F. Jackson, Shawn P. Vorce, Justin M. Holler, Stephen L. Robinson & Thomas Z. Bosy. (2016) Detection of 25C-NBOMe in Three Related Cases. Journal of Analytical Toxicology 40:6, pages 466-472.
Crossref
Crossref
Elisabeth Leere Øiestad, Åse Marit Leere Øiestad, Astrid Gjelstad & Ritva Karinen. (2016) Oral fluid drug analysis in the age of new psychoactive substances. Bioanalysis 8:7, pages 691-710.
Crossref
Crossref
Elli Tyrkkö, Mikael Andersson & Robert Kronstrand. (2016) The Toxicology of New Psychoactive Substances. Therapeutic Drug Monitoring 38:2, pages 190-216.
Crossref
Crossref
Dariusz Zuba, Piotr Adamowicz & Simon Elliott. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
935
944
.
Anna Rickli, Dino Luethi, Julian Reinisch, Danièle Buchy, Marius C. Hoener & Matthias E. Liechti. (2015) Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology 99, pages 546-553.
Crossref
Crossref
Jolanta B. Zawilska & Dariusz Andrzejczak. (2015) Next generation of novel psychoactive substances on the horizon – A complex problem to face. Drug and Alcohol Dependence 157, pages 1-17.
Crossref
Crossref
M.A. Hieger, S.R. Rose, K.L. Cumpston, P.E. Stromberg, S. Miller & B.K. Wills. (2015) Severe poisoning after self-reported use of 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, a novel substituted amphetamine: a case series. The American Journal of Emergency Medicine 33:12, pages 1843.e1-1843.e3.
Crossref
Crossref
Sara Andrabi, Spencer Greene, Nidal Moukaddam & Benjamin Li. (2015) New Drugs of Abuse and Withdrawal Syndromes. Emergency Medicine Clinics of North America 33:4, pages 779-795.
Crossref
Crossref
Joseph J. Palamar, Silvia S. Martins, Mark K. Su & Danielle C. Ompad. (2015) Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug and Alcohol Dependence 156, pages 112-119.
Crossref
Crossref
Steven Karch & Olaf Drummer. 2015. Karch's Pathology of Drug Abuse, Fifth Edition. Karch's Pathology of Drug Abuse, Fifth Edition
365
428
.
Justin L. Poklis, Stephen A. Raso, Kylie N. Alford, Alphonse Poklis & Michelle R. Peace. (2015)
Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-
N
-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper
. Journal of Analytical Toxicology 39:8, pages 617-623.
Crossref
Crossref
Joji Suzuki, Michael A. Dekker, Erin S. Valenti, Fabiola A. Arbelo Cruz, Ady M. Correa, Justin L. Poklis & Alphonse Poklis. (2015) Toxicities Associated With NBOMe Ingestion—A Novel Class of Potent Hallucinogens: A Review of the Literature. Psychosomatics 56:2, pages 129-139.
Crossref
Crossref